1CA7 | A:1-114; B:1-114; C:1-114 | MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) WITH HYDROXPHENYLPYRUVATE |
1CGQ | A:0-114; B:0-114; C:0-114 | MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) WITH ALANINE INSERTED BETWEEN PRO-1 AND MET-2 |
1DPT | A:1-117; B:1-117; C:1-117 | D-DOPACHROME TAUTOMERASE |
1GCZ | A:1-118; C:1-118; B:1-114 | MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) COMPLEXED WITH INHIBITOR. |
1GD0 | A:1-118; C:1-118; B:1-114 | HUMAN MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) |
1GIF | A:1-115; B:1-115; C:1-115 | HUMAN GLYCOSYLATION-INHIBITING FACTOR |
1LJT | A:1-114; B:1-114; C:1-114 | CRYSTAL STRUCTURE OF MACROPHAGE MIGRATION INHIBITORY FACTOR COMPLEXED WITH (S,R)-3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER (ISO-1) |
1MIF | A:2-115; B:2-115; C:2-115 | MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) |
1P1G | A:1-114; B:1-114; C:1-114 | MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) WITH PRO-1 MUTATED TO GLY-1 |
2OOH | A:1-114; B:1-114; C:1-114 | CRYSTAL STRUCTURE OF MIF BOUND TO A NOVEL INHIBITOR, OXIM-11 |
2OOW | A:1-114; B:1-114; C:1-114 | MIF BOUND TO A FLUORINATED OXIM DERIVATIVE |
2OOZ | A:1-114; B:1-114; C:1-114 | MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) COMPLEXED WITH OXIM6 (AN OXIM DERIVATIVE NOT CONTAINING A RING IN ITS R-GROUP) |
3CE4 | A:1-114; C:1-114; B:1-114 | STRUCTURE OF MACROPHAGE MIGRATION INHIBITORY FACTOR COVALENTLY INHIBITED BY PMSF TREATMENT |
3HOF | C:1-117; A:1-118; B:1-114 | STRUCTURE OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) WITH CAFFEIC ACID AT 1.9A RESOLUTION |
3IJG | A:1-114; B:1-114; C:1-114 | MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) BOUND TO THE (R)-STEREOISOMER OF AV1013 |
3IJJ | A:1-114; B:1-114; C:1-114 | TERNARY COMPLEX OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) BOUND BOTH TO 4-HYDROXYPHENYLPYRUVATE AND TO THE ALLOSTERIC INHIBITOR AV1013 (R-STEREOISOMER) |
3JSF | B:1-117; C:1-118; A:1-115 | CRYSTAL STRUCTURE OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) WITH HYDROXYQUINOLINE INHIBITOR 638 AT 1.93A RESOLUTION |
3JSG | C:1-117; B:1-114; A:1-118 | CRYSTAL STRUCTURE OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) WITH HYDROXYQUINOLINE INHIBITOR 707 AT 1.58A RESOLUTION |
3JTU | C:1-117; A:1-118; B:1-114 | CRYSTAL STRUCTURE OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) WITH HYDROXYQUINOLINE INHIBITOR 708 AT 1.86A RESOLUTION |
3L5P | B:1-117; C:1-118; A:1-114 | CRYSTAL STRUCTURE OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) WITH IMIDAZOPYRIDAZINOL INHIBITOR AT 1.80A RESOLUTION |
3L5R | B:1-118; C:1-118; A:1-114 | CRYSTAL STRUCTURE OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) WITH PHENYLCHROMENONE INHIBITOR AT 1.94A RESOLUTION |
3L5S | B:1-117; C:1-117; A:1-114 | CRYSTAL STRUCTURE OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) WITH IMIDAZOPYRIMIDINYLPHENYL INHIBITOR AT 1.86A RESOLUTION |
3L5T | B:1-117; C:1-117; A:1-114 | CRYSTAL STRUCTURE OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) WITH THIOPHENEPIPERAZINYLQUINOLINONE INHIBITOR AT 1.86A RESOLUTION |
3L5U | A:1-116; B:1-115; C:1-114 | CRYSTAL STRUCTURE OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) WITH BENZOTHIAZOLE INHIBITOR AT 1.90A RESOLUTION |
3L5V | A:1-117; C:1-118; B:1-114 | CRYSTAL STRUCTURE OF MACROPHAGE MIGRATION INHIBITORY FACTOR (MIF) WITH GLYCEROL AT 1.70A RESOLUTION |